Ara
Toplam kayıt 6, listelenen: 1-6
Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study
(Verduci, 2022)
OBJECTIVE: In this study, we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer.
PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer ...
Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer
(Verduci, 2021)
OBJECTIVE: In this study, we aimed to evaluate the prognostic value of preoperative serum ferritin level in patients with stage 2 colon cancer who underwent curative surgery.
PATIENTS AND METHODS: The data of 120 patients ...
A New Prognostic Index in Young Breast Cancer Patients
(College of Physicians and Surgeons Pakistan, 2022)
Objective:To evaluate the prognostic role of pan immune-inflammation value (PIV) in young breast cancer patients.
Study Design: Descriptive study.
Place and Duration of Study: Department of Medical Oncology, Afyon ...
Conservative Treatment of Chiari Malformation Type I Based on the Phase-Contrast Magnetic Resonance Imaging: A Retrospective Study
(Elsevier, 2022)
Background
The use of phase-contrast magnetic resonance imaging is interestingly increased in the diagnosis and follow up of patients with Chiari type I malformation (CM1). The current study aimed to elaborate the benefits ...
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
(London : Sage Publications, 2023)
Objectives: The objective of our study was to assess the prognostic significance of the Pan-Immune-Inflammation Value (PIV) before concurrent chemoradiation (C-CRT) and prophylactic cranial irradiation (PCI) in patients ...
The prognostic Vvalue of the novel global Immune-nutrition-inflammation index (GINI) in stage IIIC non-small cell lung cancer patients treated with concurrent chemoradiotherapy
(Switzerland, 2023)
Background: We sought to determine the prognostic value of the newly developed Global Immune-Nutrition-Inflammation Index (GINI) in patients with stage IIIC non-small cell lung cancer (NSCLC) who underwent definitive ...